| 摘要 |
The invention relates to the compound of the formula <CHEM> which is 2-(3,5-bis-trifluoromethyl-phenyl)-N-methyl-N-(6-morpholin-4-yl-4-o-to lylpyridin-3-yl)-isobutyramide. It has been found that this compound has a high affinity to the NK-1 receptor and it is therefore useful in the treatment of diseases, which relate to this receptor.
|
